Tagged with HE

Mexico The founder and Managing Director of Global Health Intelligence (GHI), Guillaume Corpart highlights the value of competitive intelligence for medical device companies looking to either enter emerging healthcare markets in Latin America and Asia or identify new market opportunities. As an introduction for our readers, Guillaume, could you elaborate on…

Switzerland The most innovative country in the world must constantly launch new initiatives to attract R&D activities if that lead is to be maintained, and Switzerland Innovation is doing just that – by showcasing the opportunities that the Swiss Innovation Park holds for innovative companies around the world. Switzerland Innovation was…

Mexico “Equipment is not everything that GE can contribute with!” – The CEO and President of GE Healthcare’s Mexican Unit elaborates on how GE provides added value to its customers by focusing on innovating access, cost and quality.   “The mission for me and all my peers around the world is…

Switzerland Recognized as one of the ten most innovative companies in the world, Hamilton has a regional HQ, strategic R&D and manufacturing operations tucked high away in the scenic Swiss Alps. Andreas Wieland, CEO of Hamilton’s Swiss businesses, discusses the company’s approach to innovation and the factors that have helped Switzerland…

Mexico Xavier Rams, General Director at Ferrer Mexico, explains the importance of aligning corporate strategy to public healthcare goals in order to succeed in the dynamic Mexican environment and showcases the added value that Sincronium® creates for the national healthcare system as a whole. You have been in charge of Ferrer…

Switzerland The president of BD Europe analyses current trends and challenges in European healthcare and highlights how BD is positioning itself as a solutions provider and partner to cope with this new environment. BD acquired CareFusion in 2015 and September 30th 2016 marked the end of BD’s first full fiscal year of…

Ireland The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring countries struggling to interpret what ‘Brexit’ means for them. Ireland, as the UK’s closest neighbour both culturally and geographically, could stand to benefit from the decision in the medium- to long-term, especially in…

Greece John Kandylis, GM of Greek logistics market leader Olympias, discusses his company’s unique service offering, negotiating the issues brought about by the financial crisis, and retaining a family-run spirit while expanding internationally. Olympias SA is positioned as a market leader in logistics with deep expertise in the field. Could you…

Taiwan The Chairman & CEO of TaiGen Biotechnology discusses the growth opportunities that the company holds in China, its main target market, and documents how her long-term strategic outlook made the company one of the most successful biotech companies in the region today, holding an unrivalled experience and unique positioning in…

Mexico President and CEO of Grupo ENESA, Jaime Chico Pardo breaks down the private capital fund’s core investment pillars—centered on active management and driving long-term value—while elaborating on the flourishing opportunities where technology and healthcare intersect, and how this marriage serves to close Mexico’s encroaching healthcare gaps. Jaime, can you start…

Mexico Roberto Tapia-Conyer, General Director at the Carlos Slim Foundation, explains the unique position of the Foundation to develop and introduce innovation that could create breakthroughs in the National Healthcare System as well as enhance patients’ quality of life. Could you please give our international audience an update on the operations…

Europe Europe accounts for 22.2 percent of global pharma sales; more than Africa, Asia, Australasia, and Latin America combined, but less than half of North America. The biopharmaceutical industry is a key contributor to the European economy in terms of both trade surplus and employment; especially highly-skilled R&D jobs. Germany is…